Dealmaking

LMP bets on M&A rebound in CV for SRS Acquiom; Harris Williams says 2026 offers a wealth of potential for tech buyers and sellers

We also dive into Baird's annual M&A outlook and GTCR's partnership with Gary Swidler to form Ascent Sports Group.

Quality is king, strategic options are expanding, tech is transforming the landscape and change is a constant

Harris Williams investment bankers share their views on everything from AI adoption to tech-enabled services with PE Hub.

Exclusive: Lovell Minnick Partners closes single-asset CV for SRS Acquiom

'We have been managing rapid organic growth. Now, we have the resources, and we want to ramp up M&A,' LMP's Steve Pierson told PE Hub.

Ardian’s Pauline Thomson on AI threats and opportunities; Columna to sell stake in insurance claims management company MSA Mizar to TowerBrook

Epiris has agreed to sell a structured minority interest in Pure Cremation, a funeral services provider in the UK, to Centerbridge Partners.

Ardian integrating AI risks and opportunities into deal analysis framework

Gen AI offers value creation enhancement, but portco legacy systems must first be adapted, Pauline Thomson, head of data science, told PE Hub.

Deals from KKR, ECP, Hg and OEP suggest increased M&A; Deal of the Year Award entries are due Friday

Friday is the deadline for PE Hub’s Deal of the Year Awards; recapping several significant deals announced in late December and early January: Energy Capital Partners sold Calpine Corporation, Hg agreed to acquire OneStream, One Equity Partners agreed to sell its stake in Armis; how will 2026 compare with last year's record-breaking PE investment in the aerospace and defense sector?

Short holds in focus: Carlyle’s Petr Rieger on Tescan’s rapid EBITDA growth during three-year hold; Eurazeo to sell Ex Nihilo stake to L Catterton after two years

Carlyle’s growth play at Tescan yields EBITDA boost and $850m sale  

Tescan is a manufacturer of electron microscopes and advanced scientific and analytical instruments.

Shareholder activism shaping financial services deal structures, says White & Case; IPO discussion tone shifting, finds EY’s Mark Schwartz

London-listed Auction Technology Group has this morning rebuffed the latest potential take-private offer from FitzWalter Capital.

DFW Capital, GPP, SK Capital eye pharma commercialization; Chicago Bears QB Caleb Williams’ 888 Midas gears up for future investment plays

Rounding up five deals in the pharma commercialization segment, and delving into trends driving that activity; a discussion with 888 Midas’ Ross Walker on the firm’s strategy for investing in the sports, health tech sectors over the next few years; zeroing in on Water Street Healthcare Partners’ investment in a tech-enabled company focused on optimizing hospital pharmacy operations.